Claudia Ouyang

Company: BioNTech

Job title: Director - Cell Therapy

Seminars:

Developing a Robust, Antigen-Agnostic In Silico Prediction Model to Select & Test Personalized TCRs (pTCRs) for Tumor-Reactivity 12:05 pm

Predicting tumor-reactive pTCRs via gene signature to enable target diversity and rapid TCR discovery Generating wet-lab TCR validation data in a high-throughput format to train prediction model Validating selected pTCRs using patient-derived tumor organoids to inform preclinical efficacyRead more

day: Day 1